| Literature DB >> 20822509 |
Vincent C C Cheng1, Josepha W M Tai, W M Chan, Eric H Y Lau, Jasper F W Chan, Kelvin K W To, Iris W S Li, P L Ho, K Y Yuen.
Abstract
BACKGROUND: After renovation of the adult intensive care unit (ICU) with installation of ten single rooms, an enhanced infection control program was conducted to control the spread of methicillin-resistant Staphylococcus aureus (MRSA) in our hospital.Entities:
Mesh:
Year: 2010 PMID: 20822509 PMCID: PMC2944349 DOI: 10.1186/1471-2334-10-263
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Admission data of patient managed in ICU during different phases of interventions.
| Before ICU renovation | After ICU renovation | P value | Hand hygiene campaign | P value | |
|---|---|---|---|---|---|
| Total number of patient-days | 14973 | 15501 | 17693 | ||
| Total number of admission | 3572 | 3477 | 5024 | ||
| Mean number of admission to ICU per quarter (± S.D.) | 397 (± 44) | 386 (± 53) | 0.650 | 419 (± 27) | 0.121 |
Figure 1The trend of usage density of broad-spectrum antibiotics, fluoroquinolones, and incidence density of ICU onset MRSA infection. Note. ICU, adult intensive care unit; broad-spectrum antibiotics, include cefepime, ceftazidime, and cefoperazone-sulbactam, piperacillin-tazobactam, meropenem, imipenem-cilastatin; fluoroquinolones, include ciprofloxacin, levofloxacin, and moxifloxacin; MRSA; methicillin-resistant Staphylococcus aureus. The trend of ICU onset ESBL-producing organisms' infection is listed as reference.
Figure 2The overall usage density of broad-spectrum antibiotics & fluoroquinolones in ICU during different phases of interventions. Note. ICU, adult intensive care unit; broad-spectrum antibiotics, include cefepime, ceftazidime, and cefoperazone-sulbactam, piperacillin-tazobactam, meropenem, imipenem-cilastatin; fluoroquinolones, include ciprofloxacin, levofloxacin, and moxifloxacin.
Figure 3Changes in the incidence density of infection due to MRSA and ESBL-producing organisms (per 1000-patient-days) in ICU. Note. ICU, adult intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus. ESBL-producing organisms includes E. coli and Klebsiella pneumoniae.
Change in incidence density of ICU onset infection due to MRSA and ESBL-producing organisms from interrupted time-series with segmented regression analysis during the entire study duration.
| Period comparison | ICU MRSA infection | ICU onset infection due to ESBL-producing organisms |
|---|---|---|
| Phase 2 vs Phase 1 | ||
| Level change | 1.188 (p = 0.252) | 3.541 (p = 0.091) |
| Trend change | 0.161 (p = 0.415) | -0.135 (p = 0.727) |
| Phase 3 vs Phase 2 | ||
| Level change | 0.290 (p = 0.757) | 1.052 (p = 0.570) |
| Trend change | 0.173 (p = 0.300) | 0.547 (p = 0.103) |
| Post-SARS vs Pre-SARS* | ||
| Level change | -3.337 (p < 0.001) | -1.560 (p = 0.413) |
| Trend change | -0.658 (p = 0.021) | -0.022 (p = 0.975) |
Note. SARS, severe acute respiratory syndrome
* Pre-SARS period is defined as the time between 2002 1Q to 2003 1Q and post-SARS period is defined as the time between 2003 2Q to 2009 2Q
Figure 4Change in incidence density of ICU onset infection due to MRSA and ESBL-producing organisms from interrupted time-series with segmented regression analysis according to different phases of interventions.
Figure 5Change in incidence density of ICU onset infection due to MRSA and ESBL-producing organisms from interrupted time-series with segmented regression analysis before and after the outbreak of severe acute respiratory syndrome (SARS) in 2003 2Q. Note. Pre-SARS period is defined as the time between 2002 1Q to 2003 1Q and post-SARS period is defined as the time between 2003 2Q to 2009 2Q.
Review of literature on the single room isolation and/or hand hygiene practice as the predominant measures to control the spread of methicillin-resistant Staphylococcus aureus in adult intensive care unit.
| Study [reference] | Design and setting | Main intervention | Major outcome | Remark |
|---|---|---|---|---|
| Cepeda JA | Prospective 12-month study in the ICU of 2 teaching hospitals (18-bed for hospital A & 10-bed for hospital B), London, UK | Phase 1 (6-month): all MRSA-positive patients were moved to single room or cohort nursed | MRSA acquisition rates in ICU were similar in phase 1 and 2 | Suboptimal patient screening, delay in the availability of MRSA results, and low adherence to hand hygiene (21%) |
| Huang SS | Retrospective 9-year study in 8 ICUs in an 800-bed hospital, Boston, US | Phase 1 (since 1 Sept 2000): campaign for sterile CVC placement | Significant reduction in MRSA bacteremia by 75% (p = 0.007) in ICU during phase 4 | Other interventions were not associated with a significant change in MRSA bacteremia |
| Bracco D | Prospective 30-month study in a 18-bed medico-surgical ICU (6 single-bed rooms plus a 6-bed and 2-bed bay room), Montreal, Canada | Placement of patients into single room or bay room according to the availability of place | The rate of MRSA acquisition was significantly lower in single room (1.3 per 1000-patient-days) than bay room (4.1 per 1000-patient-days) (p < 0.001) | Placement in single room may reduce MRSA cross-transmission in the institution where MRSA is not hyperendemic |
| Gastmeier P | Questionnaire surveillance to 212 ICUs participating in KISS | To enquire the infection control practice in preventing nosocomial MRSA infection; univariate and multivariate analyses to identify risk factors for nosocomial MRSA infection | 164 (77.4%) ICUs response; placement in isolation rooms or cohorts was found to be a protective factor (OR, 0.36; CI95, 0.17-0.79) in multivariate analysis | Up to 34% of the German ICUs have not isolated MRSA patients in single rooms or cohorts |
| Harrington G et al (2007) | Prospective 40-month study in a 35-bed ICU, Melbourne, Australia | Introduction of antimicrobial hand hygiene gel with the consumption of hand hygiene product increased from 78.1 liters per 1000-patient-days to 102.7 liters per 1000-patient-days | The rate of MRSA acquisition was significant lower in post-intervention (6.7 per 100 patient admission) than baseline (9.3 per 100 admission) (p = 0.047) | No admission and weekly screening for MRSA; no placement of MRSA patient in single room |
| Souweine B | Prospective 4-month study in 2 ICUs (10-bed in a University hospital and 8-bed in a non-teaching hospital), France | Provision of alcohol-based hand rub during the intervention period | No significant reduction in MRSA colonization and infection after intervention | The sample size was underpower to estimate the difference |
Note. CI95, 95% confidence interval; CVC, central venous catheter; ICU, intensive care unit; KISS, Krankenhaus Infektions Surveillance System (German Nosocomial Infection Surveillance System); MRSA, methicillin-resistant Staphylococcus aureus; OR, odd ratio